- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Eagan Today
By the People, for the People
Anteris Technologies Global Posts Quarterly Earnings Results
The medical device company reported a loss per share of $0.75 for the quarter.
Published on Mar. 3, 2026
Got story updates? Submit your updates here. ›
Anteris Technologies Global (NASDAQ:AVR), a medical device company focused on heart disease treatments, released its quarterly earnings report on Thursday. The company reported a loss per share of $0.75 for the quarter, with revenue of $0.31 million. Anteris Technologies Global had a negative net margin of 4,921.27% and a negative return on equity of 400.59%.
Why it matters
Anteris Technologies Global's quarterly results provide insight into the financial performance and progress of the company as it develops and commercializes medical devices for heart diseases. The company's financial metrics and market performance are closely watched by investors and analysts to gauge the viability and growth potential of the business.
The details
Anteris Technologies Global reported a loss per share of $0.75 for the quarter, which was lower than analysts' expectations. The company's revenue for the quarter was $0.31 million. Anteris Technologies Global had a negative net margin of 4,921.27% and a negative return on equity of 400.59%. The company's stock traded up $0.17, or 2.6%, to $6.51 per share on Friday.
- Anteris Technologies Global released its quarterly earnings data on Thursday, February 28, 2026.
- The company's stock traded on Friday, February 29, 2026.
The players
Anteris Technologies Global
A medical device company focused on developing and commercializing treatments for heart diseases.
The takeaway
Anteris Technologies Global's quarterly financial results provide a snapshot of the company's performance as it continues to develop and commercialize its medical devices for heart diseases. Investors and analysts will closely monitor the company's progress and financial metrics to assess the viability and growth potential of the business.
